secwatch.observer — SEC 8-K summary
======================================

Issuer:     Breeze Holdings Acquisition Corp. (—)
CIK:        0001817640
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0001213900-25-024825
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Breeze Holdings gets OTCQX delisting notice; merger with YD Biopharma planned by June 13
--------------------------------------------------------------------------------

- Received OTCQX non-compliance notice on March 17, 2025; cure deadline June 13, 2025.
- Must meet net tangible assets ($2M if 3+ yrs or $5M if less), avg revenue $6M, or bid price $5/share.
- Pursuing business combination with YD Biopharma Limited expected to close before June 13, 2025.
- Combined company required to list on NASDAQ Capital Markets at closing.
- If not cured, common stock BRZH and warrants BRZHW will be moved from OTCQX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817640/000121390025024825/0001213900-25-024825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817640/000121390025024825/ea0234901-8k_breeze.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-024825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer